COVID-19 Emergency Test Authorization Will End in December
Federal emergency use authorizations for COVID-19 tests will conclude on December 26, 2026, shifting testing protocols.
Updated on Oct. 14, 2026 in COVID-19
Live Poll
Should government agencies maintain emergency health authorizations longer to prevent supply shortages for the public?
The Department of Health and Human Services announced that the emergency use authorization for COVID-19 tests will officially end on December 26, 2026. This transition marks the conclusion of temporary regulatory measures that have been in place since the pandemic began.
Why it matters
The federal government determined that the emergency use authorization status for these diagnostic tools is no longer necessary. This policy change requires test manufacturers to secure full FDA approval to continue distributing their products in the United States.
The transition is based on a federal determination by the Department of Health and Human Services to end temporary regulatory measures. While current lab inventories remain usable until they expire, the status of long-term availability for specific tests remains subject to full FDA approval.
The players
Department of Health and Human Services
The federal agency responsible for overseeing public health policy and the implementation of emergency regulatory frameworks in the United States.
Food and Drug Administration
The federal agency that regulates medical devices and determines the safety and efficacy standards required for full product approval.
The details
To maintain market availability, manufacturers are required to submit and obtain full FDA approval for their diagnostic tests by the December 26, 2026, deadline. Labs are advised to verify whether their current testing platforms are operating under the expiring emergency rules or have already transitioned to full approval. If manufacturers do not secure full approval, labs will need to pivot to fully authorized testing alternatives to ensure continued clinical operations.
Timeline
June 2026: The Department of Health and Human Services announced the end of the emergency use authorization.
December 26, 2026: The federal emergency use authorization for COVID-19 tests officially ends.
Health Landscape
This policy change represents the final phase of transitioning pandemic-era diagnostic tools into the standard federal regulatory framework. It marks a shift from rapid emergency clearance to long-term clinical validation protocols mandated by the FDA.
If you are concerned about testing availability at your local provider, consider speaking with your primary care physician about their current testing protocols. Most patients will not see a disruption in care, but it is worth noting that diagnostic infrastructure is shifting toward fully approved products.
The takeaway
The end of emergency use status means diagnostic labs and manufacturers are moving toward permanent regulatory compliance. If you have questions about specific diagnostic test reliability, the best step is to consult with your physician regarding the clinical tests used in their practice.
Further reading
For more information on current diagnostic standards, visit the COVID-19 section.
More information
You can find a list of fully FDA approved tests on the agency's official website.
Source note: This article includes information reported by NorthcentralPA.
Live Poll
Should government agencies maintain emergency health authorizations longer to prevent supply shortages for the public?
